Roche responds to adoption of shareholder rights plan by Illumina Board of Directors
BASEL - Roche responded to an announcement from Illumina, Inc. that its Board of Directors has adopted a shareholder rights plan.
read more
For CML, Nilotinib Superior to Imatinib at 24 Months
US - Nilotinib continues at 24 months to protect patients with chronic myeloid leukemia from the development of emerging mutations and progression to advanced disease.
read more
Janssen Healthcare Innovation Announces JANSSEN CONNECTED CARE CHALLENGE to Spur Innovation in Patient Care
WASHINGTON D.C. - Janssen Healthcare Innovation , a team within Janssen Research & Development, LLC., announced the Janssen Connected Care Challenge at the Health Care Innovations Summit in Washington...
read more
GE To Fold Web-Based EHR
GE Healthcare is discontinuing a Web-based ambulatory electronic health record product it purchased less than two years ago.
read more
Innovative drug approvals up sharply in 2011, gov’t increasingly funds infectious disease R&D
WASHINGTON - The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new...
read more
Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care
SOUTH SAN FRANCISCO - Janssen Alzheimer Immunotherapy, together with its collaborator on the Alzheimer’s Immunotherapy Program, Pfizer Inc., and the Geoffrey Beene Gives Back Alzheimer’s Initiative in...
read more
Teva Partnership And Pipeline Potential: Why Antares Is A Buy
US -The failure of the Libi-Gel trial rocked the stock of Antares (AIS) and caused it to drop from around $2.62 to $1.67, with a subsequent recovery to $2.40.
read more
Dow and Monsanto Team Up on the Mother of All Herbicide Marketing Plans
US - During the late December media lull, the USDA didn't satisfy itself with green-lighting Monsanto's useless, PR-centric "drought-tolerant" corn.
read more
Bruker Acquires Hecus MICROcaliX Product Line to Expand Product Portfolio for Small Angle X-ray Scattering
KARLSRUHE, Germany - Bruker AXS GmbH announced that it has acquired the assets of Hecus X-ray Systems GmbH, a company focused on analytical instrumentation for Small Angle X-ray Scattering based on ad...
read more
Avastin-based regimen extends survival when continued beyond initial treatment in patients with metastatic colorectal cancer
BASEL, Switzerland - Roche announced that a phase III study in metastatic colorectal cancer met its primary endpoint of overall survival.
read more
|